As of the latest SEC filings, Lexeo Therapeutics, Inc. (LXEO) is held by 134 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $12,968,152.40 in market value, representing a significant portion of its portfolio.
Funds holding Lexeo Therapeutics, Inc. (LXEO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- LXEO
- CIK:
- 0001907108
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $12,968,152.40 | 2,259,260 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.14% | $10,691,938.18 | 1,862,707 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $9,367,840.72 | 1,632,028 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $3,855,827.78 | 671,747 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $3,725,367.17 | 654,147 | Apr 30, 2026 | Jun 26, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.07% | $3,636,209.64 | 633,486 | Mar 31, 2026 | May 29, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.03% | $3,228,457.26 | 562,449 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.03% | $2,625,745.78 | 457,447 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.01% | $2,240,597.98 | 312,061 | Feb 28, 2026 | Apr 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.01% | $2,234,372.92 | 311,194 | Feb 28, 2026 | Apr 24, 2026 |
|
KOMP
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF
|
ETF | State Street (SPDR) | 0.08% | $1,847,866.72 | 321,928 | Mar 31, 2026 | May 28, 2026 |
|
VFMO
VANGUARD U.S. MOMENTUM FACTOR ETF
|
ETF | Vanguard | 0.11% | $1,578,465.56 | 219,842 | Feb 28, 2026 | Apr 28, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.25% | $1,411,488.96 | 245,904 | Mar 31, 2026 | May 29, 2026 |
|
DFAS
Dimensional U.S. Small Cap ETF
|
ETF | Dimensional Fund Advisors | 0.01% | $1,398,019.99 | 245,482 | Apr 30, 2026 | Jun 29, 2026 |
|
DFSTX
U.S. SMALL CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.01% | $1,321,991.74 | 232,132 | Apr 30, 2026 | Jun 24, 2026 |
|
DWAS
Invesco Dorsey Wright SmallCap Momentum ETF
|
ETF | Invesco | 0.31% | $1,207,159.04 | 168,128 | Feb 28, 2026 | Apr 28, 2026 |
|
DFSCX
U.S. MICRO CAP PORTFOLIO
|
MF | Dimensional Fund Advisors | 0.02% | $1,151,939.04 | 202,272 | Apr 30, 2026 | Jun 24, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.08% | $949,487.84 | 165,416 | Mar 31, 2026 | May 28, 2026 |
|
GTTUX
Goldman Sachs Small Cap Value Insights Fund
|
MF | Goldman Sachs | 0.08% | $855,838.91 | 150,279 | Apr 30, 2026 | Jun 22, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $833,562.10 | 116,095 | Feb 28, 2026 | Apr 24, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $828,013.14 | 145,393 | Apr 30, 2026 | Jun 25, 2026 |
|
GDSTX
Goldman Sachs Small Cap Equity Insights Fund
|
MF | Goldman Sachs | 0.09% | $679,066.11 | 119,239 | Apr 30, 2026 | Jun 22, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $662,010.36 | 92,202 | Feb 28, 2026 | Apr 24, 2026 |
|
DFAC
Dimensional U.S. Core Equity 2 ETF
|
ETF | Dimensional Fund Advisors | 0.00% | $630,937.66 | 110,788 | Apr 30, 2026 | Jun 29, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 0.12% | $618,448.53 | 108,595 | Apr 30, 2026 | Jun 29, 2026 |
Advertisement (320x50)